BNP Paribas Discount Zert MRNA 30.../ DE000PN53V23 /
5/28/2024 3:30:15 PM | Chg.-1.34 | Bid3:44:10 PM | Ask3:44:10 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
114.06EUR | -1.16% | 113.06 Bid Size: 200 |
113.11 Ask Size: 200 |
Moderna Inc | - USD | 12/30/2024 | Call |
GlobeNewswire
5/22
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
5/12
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
5/8
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/8
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
5/2
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/1
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
5/1
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire
4/4
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
GlobeNewswire
3/4
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024